ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

New Cancer Awards Worth $1 Million a Year Announced

September 30, 1988

New Organization To Develop Curriculum To Teach Oncologists How To Talk To Patients.

January 19, 2001